Post Reply
1-20 of 70
$Clearbridge(1H3.SI) This article articulate clearly why Sinopharm is in demand.
" Mr Javier Chua, 20, has a low blood platelet count and health conditions that often make him feel breathless.
His mother Wini Thng, 52, was worried about side effects if he took any of the two mRNA vaccines used in Singapore' s national Covid-19 inoculation drive.
Her preference was for a traditional form of vaccine that uses an inactivated virus, such as the Sinopharm shot."
In addition, Sinopharm is deem to be more effective than sinovac.
https://www.tnp.sg/news/singapore/healthcare-firms-see-big-demand-sinopharm-vaccine
roller coaster 1 day. Power.
BB not ready to cheong 😂
BB not ready to cheong 😂
shk363 ( Date: 30-Jul-2021 17:50) Posted:
|
haha
tankoksee ( Date: 30-Jul-2021 17:48) Posted:
|
down?
shk363 ( Date: 30-Jul-2021 12:04) Posted:
|
looks like moving
Now price at low. Still collect not enough? 🤔
easy hook to 15/16/17...
easy hook to 15/16/17...
MarcLim ( Date: 29-Jul-2021 14:14) Posted:
|
can monitor this... 135/136/137 small movement, Adang awaking...
result coming in aug, profits again...
result coming in aug, profits again...
For_The_Next_Leg ( Date: 26-Jul-2021 10:36) Posted:
|
$Clearbridge(1H3.SI)
Indonesia and Philippines has to work on their vaccination efforts.
https://www.csis.org/programs/southeast-asia-program/projects/southeast-asia-covid-19-tracker
time to chiong like sanli?
For_The_Next_Leg ( Date: 22-Jul-2021 12:33) Posted:
|
$Clearbridge(1H3.SI)
I was looking thru the slides and the FY2020. With all issuance of preference shares plus disposal of these shares (for a overall cash amt of US$2.2m) plus the existing cash in their balance sheet - it will be interesting to see where these funds will be placed in the future?
That' s something to ponder about and hopefully it will be released soon.
https://links.sgx.com/1.0.0/corporate-announcements/RSMZI73DF38WRUYX/0d80d9076e0b7b7c25241ef46fb2b60adf5fa18901a03c81ed66d976ae3080f8
$Clearbridge(1H3.SI) This is not new. But shows how testing is done in Indonesia and Philippines.
https://www.reportingasean.net/poster-covid-19-testing-done-southeast-asia/
$Clearbridge(1H3.SI) It just won' t stop. Hopefully the Philippines government engage more help from Clearbridge and try to get everyone vaccinated.
https://www.channelnewsasia.com/news/asia/philippines-detects-first-local-covid-19-transmission-of-delta-15231388
$Clearbridge(1H3.SI) It will be interesting to see if Indonesia and Philippines take cue from Singapore and to proceed with a similar view. In that sense, the company could stand to benefit as they can proceed as a distributor for testing kits.
https://www.straitstimes.com/singapore/health/moving-from-covid-19-pandemic-to-endemic
some accumulation at 142
$Clearbridge(1H3.SI)
The company has not lost the suit. Just a matter of where to file the suit.
A LAWSUIT filed by a joint venture partner of a ClearBridge Health unit has been dismissed by an Indonesian court due to a jurisdiction issue, the Catalist-listed company announced in a Tuesday bourse filing.
https://www.businesstimes.com.sg/companies-markets/lawsuit-against-two-clearbridge-units-dismissed-over-jurisdiction-issue
I did not know you are holding this counter? Hahaha......
I use to hold this counter but let go evenutally.
At the end of the day, did not profit but lost money on the brokerage fees. Lol.....
I use to hold this counter but let go evenutally.
At the end of the day, did not profit but lost money on the brokerage fees. Lol.....
PhillipTan ( Date: 09-Jun-2021 09:23) Posted:
|
Medical-related companies continue to command strong investor interest with their resiliency and defensive nature...Looking forward to more of Jeremy' s magic touch for Clearbridge..
Coalition Capital, Warburg Pincus vie for US$1b Fullerton Health: sources
FRI, JUN 11, 2021 - 3:07 PM
[KUALA LUMPUR] Private equity firms Coalition Capital Partners and Warburg Pincus have been shortlisted to buy Singaporean medical services provider Fullerton Healthcare Corp in a deal that could be worth about US$1 billion, according to people with the knowledge of the matter.
Binding bids from the US and South-east Asian buyout firms are expected before the end of the month, said the people, who asked not to be named as the process is private. Other suitors could emerge and there is no guarantee that a sale will be completed, the people said.
Any deal would add to the US$7.7 billion in healthcare services M& A in Asia Pacific this year, data compiled by Bloomberg show. Besides Fullerton, Malaysia' s Sunway Group is also seeking to sell an interest in a healthcare business in the region, Bloomberg News reported last year.
Fullerton Health, whose owners include Singaporean private equity firm SIN Capital Group, tapped Bank of America to revive the previously stalled sale because the pandemic has helped boost its business, the people said in January.
The company, which was founded in 2010, operates medical facilities in nine Asia-Pacific markets from China to Malaysia and Australia, offering general practitioner, screening and diagnostics services, according to its website.
Backed by Ping An Insurance Group, it is also working with We Doctor Holdings in China to set up primary care and specialist outpatient clinics.
A representative for Warburg Pincus declined to comment. Representatives for Coalition Capital and Fullerton Health did not respond to requests for comment.
Coalition Capital, Warburg Pincus vie for US$1b Fullerton Health: sources
FRI, JUN 11, 2021 - 3:07 PM
[KUALA LUMPUR] Private equity firms Coalition Capital Partners and Warburg Pincus have been shortlisted to buy Singaporean medical services provider Fullerton Healthcare Corp in a deal that could be worth about US$1 billion, according to people with the knowledge of the matter.
Binding bids from the US and South-east Asian buyout firms are expected before the end of the month, said the people, who asked not to be named as the process is private. Other suitors could emerge and there is no guarantee that a sale will be completed, the people said.
Any deal would add to the US$7.7 billion in healthcare services M& A in Asia Pacific this year, data compiled by Bloomberg show. Besides Fullerton, Malaysia' s Sunway Group is also seeking to sell an interest in a healthcare business in the region, Bloomberg News reported last year.
Fullerton Health, whose owners include Singaporean private equity firm SIN Capital Group, tapped Bank of America to revive the previously stalled sale because the pandemic has helped boost its business, the people said in January.
The company, which was founded in 2010, operates medical facilities in nine Asia-Pacific markets from China to Malaysia and Australia, offering general practitioner, screening and diagnostics services, according to its website.
Backed by Ping An Insurance Group, it is also working with We Doctor Holdings in China to set up primary care and specialist outpatient clinics.
A representative for Warburg Pincus declined to comment. Representatives for Coalition Capital and Fullerton Health did not respond to requests for comment.
A lawsuit filed by a joint venture partner of a ClearBridge Health unit has been dismissed by an Indonesian court due to a jurisdiction issue, the Catalist-listed company announced in a Tuesday bourse filing.
In mid-2020, Clearbridge disclosed that its unit Clearbridge Medical Asia and indirect subsidiary Tirta Medika Jaya (TMJ) were being sued by Tirta Medika Nusantara (TMN), a shareholder of TMJ. TMN was seeking damages of 1.06 trillion rupiah (S$102 million) relating to a notarial deed.
At a hearing on Monday, the North Jakarta District Court dismissed the lawsuit on the basis that pursuant to the shareholders' agreement of TMJ, the court did not have jurisdiction to hear the suit.
The North Jakarta Court also directed TMN to pay the court administrative fees of about S$153.35. TMN may submit an appeal within 14 days after June 7.
Shares of Clearbridge closed at S$0.15 on Tuesday, down 0.66 per cent.
Clearbridge shd reach out to more countries to market their Biolidics test kits, as more countries globally, including Singapore, are adopting rapid tests to contain the rapid covid spreading.
Even Taiwan in their latest news, is adopting rapid testing, as quote:
" Taipei, June 7 (CNA) As the COVID-19 outbreak in Taiwan shows no signs of abating, the government plans to encourage companies to import rapid coronavirus test kits for use at home to expand COVID-19 testing capacity, the Central Epidemic Command Center (CECC) said Monday.
The CECC came up with the initiative after agreeing late last month that businesses could set up rapid testing centers to test their employees for COVID-19. ... ... "
Anyway, if kongsi wants more rev and profits, their marketing has to work harder to distribute more, esp now.
Even Taiwan in their latest news, is adopting rapid testing, as quote:
" Taipei, June 7 (CNA) As the COVID-19 outbreak in Taiwan shows no signs of abating, the government plans to encourage companies to import rapid coronavirus test kits for use at home to expand COVID-19 testing capacity, the Central Epidemic Command Center (CECC) said Monday.
The CECC came up with the initiative after agreeing late last month that businesses could set up rapid testing centers to test their employees for COVID-19. ... ... "
Anyway, if kongsi wants more rev and profits, their marketing has to work harder to distribute more, esp now.
For_The_Next_Leg ( Date: 07-Jun-2021 22:37) Posted:
|
$Clearbridge(1H3.SI)
Indonesia will definitely need more testing as stated in the report. This could benefit the company if they still have Biolidics distribution rights. Cause it has been more than 1 year already.
https://scroll.in/article/996595/why-indonesia-could-be-on-the-cusp-of-a-major-covid-19-spike